Hepatitis C patients of India get New Drugs
Written by : SMTV24x7 | Tue, May 09, 2017, 06:25 PM
NEW DELHI MAY 09: A good news for hepatitis patients.
Natco Pharma has launched sofosbuvir 400 mg, velpatasvir 100 mg tablets for Hepatitis C, patients in India.
The company said that they have launched the medicines because of rising Hepatitis cases in India.
The company said that the tablets launched are the generic version of Epclusa tablets.
we know that Epclusa medicine is used to treat patients suffering from Hepatitis C.
The company priced its tablets at an MRP of Rs 18,500 for a bottle of 28 tablets in India.
The company said, "it has signed an agreement with Gilead Sciences Inc to manufacture and sell generic versions of Hepatitis drugs."
Finally, Hepatitis C patients in India get generic medicines.